<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37080574</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2300171</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.00171-2023</ELocationID><Abstract><AbstractText><b>The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE</b> https://bit.ly/3IjvWL3</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>Cindy M M</ForeName><Initials>CMM</Initials><Identifier Source="ORCID">0000-0002-2310-5820</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2025-1734</Identifier><AffiliationInfo><Affiliation>Department of Haematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bemelmans</LastName><ForeName>Remy H H</ForeName><Initials>RHH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Gelderse Vallei, Ede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boersma</LastName><ForeName>Wim G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, North West Hospital Alkmaar, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Borst</LastName><ForeName>Bram</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4597-2722</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burggraaf</LastName><ForeName>J Louise I</ForeName><Initials>JLI</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cannegieter</LastName><ForeName>Suzanne C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-4707-2303</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ten Cate-Hoek</LastName><ForeName>Arina J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Thrombosis Expertise Center Maastricht and Department of Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), School for Cardiovascular Diseases, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croles</LastName><ForeName>F Nanne</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital St. Jansdal, Harderwijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faber</LastName><ForeName>Harald J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Wilhelmina Hospital Assen, Assen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faber</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rode Kruis Hospital, Beverwijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellemons</LastName><ForeName>Merel E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-6666-5027</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Erasmus MC Transplant Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hessels</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-0564-1064</Identifier><AffiliationInfo><Affiliation>Department of Pulmonology, North West Hospital Alkmaar, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huisman</LastName><ForeName>Menno V</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0003-1423-5348</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamphuisen</LastName><ForeName>Pieter W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Vascular Medicine, Amsterdam University Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koster</LastName><ForeName>Stephanie C E</ForeName><Initials>SCE</Initials><Identifier Source="ORCID">0000-0001-6667-6714</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Zaans Medical Centre, Zaandam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroft</LastName><ForeName>Lucia J M</ForeName><Initials>LJM</Initials><Identifier Source="ORCID">0000-0002-4734-8616</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lee</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Spaarne Hospital, Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leentjens</LastName><ForeName>Jenneke</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3356-3910</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ninaber</LastName><ForeName>Maarten K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sondermeijer</LastName><ForeName>Brigitte M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Spaarne Hospital, Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stads</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Ikazia Hospital, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonk Noordegraaf</LastName><ForeName>Anton</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4057-758X</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winckers</LastName><ForeName>Kristien</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Thrombosis Expertise Center Maastricht and Department of Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), School for Cardiovascular Diseases, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruip</LastName><ForeName>Marieke J H A</ForeName><Initials>MJHA</Initials><Identifier Source="ORCID">0000-0002-0265-4871</Identifier><AffiliationInfo><Affiliation>Department of Haematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><Identifier Source="ORCID">0000-0001-9961-0754</Identifier><AffiliationInfo><Affiliation>Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands f.a.klok@lumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch COVID &amp; Thrombosis Coalition investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="Y">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="eng"><AbstractText>The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) in coronavirus disease 2019 (COVID-19) survivors who were diagnosed with acute pulmonary embolism (PE) is currently unknown. Considering the high PE incidence reported in COVID-19 and its potentially unique pathophysiology, it may be hypothesised that thrombus resolution occurs to a lesser extent after COVID-19-associated PE, and that the prevalence of CTEPH is higher compared to non-COVID-19-associated PE populations. CTEPH could therefore be a treatable cause of long COVID, which captures a broad range of post-acute COVID-19 sequelae, in those with PE during acute COVID-19 [1]. In this multicentre cross-sectional study, we aimed to establish the prevalence of CTEPH and recurrent venous thromboembolism (VTE), and evaluate thrombus resolution in COVID-19-associated PE survivors.</AbstractText></OtherAbstract><CoiStatement>Conflict of interest: M.E. Hellemons reports honoraria for lectures (unrestricted) from Boehringer Ingelheim and Pfizer. M.V. Huisman reports grants or contracts from the Dutch Heart Foundation, ZonMW, Bayer Health Care, Pfizer-BMS and Leo Pharma, all outside this work. J. Leentjens reports payments from BMS-Pfizer, consulting fees from Viatris, contracts from Synapse, all unrelated to this work and paid to her institution. K. Meijer reports speaker fees from Alexion, Bayer and CSL Behring, participation in trial steering committees for Bayer and AstraZeneca, consulting fees from Uniqure, participation in data monitoring and endpoint adjudication committee for Octapharma, all unrelated to this work and paid to her institution. M.J.H.A. Kruip reports grants from The Netherlands Organisation for Health Research and Development, the Dutch Thrombosis Association and Sobi, speaker fees from Sobi, Roche and BMS, all paid to her institution. F.A. Klok reports grants or contracts from Bayer, BMS, BSCI, MSD, Leo Pharma, Actelion, Pharm-X, The Netherlands Organisation for Health Research and Development, the Dutch Thrombosis Association, The Dutch Heart Foundation and the Horizon Europe Program, all unrelated to this work and paid to his institution. C.M.M. de Jong, C. Visser, R.H.H. Bemelmans, W.G. Boersma, B. van den Borst, J.L.I. Burggraaf, S.C. Cannegieter, A.J. ten Cate-Hoek, F.N. Croles, H.J. Faber, L.M. Faber, L.M. Hessels, P.W. Kamphuisen, S.C.E. Koster, L.J.M. Kroft, I. van der Lee, M.K. Ninaber, B.M. Sondermeijer, S. Stads, A. Vonk Noordegraaf and K. Winckers report no conflicts of interest related to this project.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37080574</ArticleId><ArticleId IdType="pmc">PMC10116061</ArticleId><ArticleId IdType="doi">10.1183/13993003.00171-2023</ArticleId><ArticleId IdType="pii">13993003.00171-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021: 27: 601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruip M, Cannegieter SC, Ten Cate H, et al. . Caging the dragon: research approach to COVID-19-related thrombosis. Res Pract Thromb Haemost 2021: 5: 278&#x2013;290. doi:10.1002/rth2.12470</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12470</ArticleId><ArticleId IdType="pmc">PMC7938618</ArticleId><ArticleId IdType="pubmed">33733026</ArticleId></ArticleIdList></Reference><Reference><Citation>Humbert M, Kovacs G, Hoeper MM, et al. . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43: 3618&#x2013;3731. doi:10.1093/eurheartj/ehac237</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac237</ArticleId><ArticleId IdType="pubmed">36017548</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon G, Ende-Verhaar YM, Bavalia R, et al. . Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study. Thorax 2021; 76: 1002&#x2013;1009. doi:10.1136/thoraxjnl-2020-216324</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216324</ArticleId><ArticleId IdType="pubmed">33758073</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcroix M, Torbicki A, Gopalan D, et al. . ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 2021; 57: 2002828. doi:10.1183/13993003.02828-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02828-2020</ArticleId><ArticleId IdType="pubmed">33334946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie CA, Johnson MM, Stowell JT, et al. . Resolution of acute pulmonary embolism using anticoagulation therapy alone in coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord 2022; 10: 578&#x2013;584.e2. doi:10.1016/j.jvsv.2021.12.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2021.12.086</ArticleId><ArticleId IdType="pmc">PMC8786402</ArticleId><ArticleId IdType="pubmed">35085829</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte MB, Barker R, Kelly PA, et al. . Three-month follow-up of pulmonary embolism in patients with COVID-19. Thromb Res 2021; 201: 113&#x2013;115. doi:10.1016/j.thromres.2021.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.02.023</ArticleId><ArticleId IdType="pmc">PMC7908844</ArticleId><ArticleId IdType="pubmed">33662797</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese C, Annunziata A, Flora M, et al. . Three month follow-up of patients with COVID-19 pneumonia complicated by pulmonary embolism. Front Mol Biosci 2021; 8: 809186. doi:10.3389/fmolb.2021.809186</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.809186</ArticleId><ArticleId IdType="pmc">PMC8850371</ArticleId><ArticleId IdType="pubmed">35187074</ArticleId></ArticleIdList></Reference><Reference><Citation>Berghaus TM, Bader S, Faul C, et al. . Lung perfusion assessed by SPECT/CT after a minimum of three months anticoagulation therapy in patients with SARS-CoV-2-associated acute pulmonary embolism: a retrospective observational study. Respir Res 2022; 23: 296. doi:10.1186/s12931-022-02188-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02188-2</ArticleId><ArticleId IdType="pmc">PMC9620596</ArticleId><ArticleId IdType="pubmed">36316693</ArticleId></ArticleIdList></Reference><Reference><Citation>den Exter PL, van Es J, Kroft LJ, et al. . Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism. Thromb Haemost 2015; 114: 26&#x2013;34. doi:10.1160/TH14-10-0842</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH14-10-0842</ArticleId><ArticleId IdType="pubmed">26017397</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G, Roldan-Valadez E, Graniel-Palafox LE, et al. . Chronic thromboembolic pulmonary hypertension (CTEPH): a review of another sequel of severe post-Covid-19 pneumonia. Curr Probl Cardiol 2022; in press [10.1016/j.cpcardiol.2022.101187]. doi:10.1016/j.cpcardiol.2022.101187</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101187</ArticleId><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101187</ArticleId><ArticleId IdType="pmc">PMC8956357</ArticleId><ArticleId IdType="pubmed">35346727</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman J, Boubriak I, Jenkins D, et al. . Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset. ERJ Open Res 2021; 7: 00431-2021. doi:10.1183/23120541.00431-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00431-2021</ArticleId><ArticleId IdType="pmc">PMC8419584</ArticleId><ArticleId IdType="pubmed">34646880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. . Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 2017; 49: 1601792. doi:10.1183/13993003.01792-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01792-2016</ArticleId><ArticleId IdType="pubmed">28232411</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerio L, Mavromanoli AC, Barco S, et al. . Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur Heart J 2022: 43: 3387&#x2013;3398. doi:10.1093/eurheartj/ehac206</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac206</ArticleId><ArticleId IdType="pmc">PMC9492241</ArticleId><ArticleId IdType="pubmed">35484821</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara-Palomares L, Bikdeli B, Jim&#xe9;nez D, et al. . Rate of recurrence after discontinuing anticoagulation therapy in patients with COVID-19-associated venous thromboembolism. JAMA Intern Med 2022; 182: 1326&#x2013;1328. doi:10.1001/jamainternmed.2022.4954</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.4954</ArticleId><ArticleId IdType="pmc">PMC9641587</ArticleId><ArticleId IdType="pubmed">36342711</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>